INTRODUCTION AND OBJECTIVES: Often, high-volume databases (eg. SEER) contain insufficient detail about underlying diseases and results drawn from such datasets represent weak evidence. Detailed information is present in narrative clinical documentation, but it is costly/ time-consuming to make it computable for analyses. With advent of machine learning and natural language processing(NLP), an automated approach is viable to generate detailed high-volume research data. To introduce a NLP pipeline for clinical named entity recognition(NER) with machine learning classification to extract detailed information from narratively written pathological radical prostatectomy(RP) electronic health records(EHR).
INTRODUCTION AND OBJECTIVES: Often, high-volume databases (eg. SEER) contain insufficient detail about underlying diseases and results drawn from such datasets represent weak evidence. Detailed information is present in narrative clinical documentation, but it is costly/ time-consuming to make it computable for analyses. With advent of machine learning and natural language processing(NLP), an automated approach is viable to generate detailed high-volume research data. To introduce a NLP pipeline for clinical named entity recognition(NER) with machine learning classification to extract detailed information from narratively written pathological radical prostatectomy(RP) electronic health records(EHR).
METHODS: Prospectively recorded institutional RP pathological database served as gold-standard. Overall, 3,679 RP EHR were randomly split into 70% training-and 30% test-datasets. First, all training EHR were automatically annotated by utilizing regular expressions, engineered for the task of extracting name entities. These expressions were parameterized with gold-standard encoding values. This approach enabled to provide a semi-automatically annotated corpus of narratively written pathological reports containing the initially context-free gold-standard encodings. Following pathological variables were identified: Primary/secondary Gleason pattern, corresponding percentages, tumor and nodal stage, total and tumor volume, maximum diameter and surgical margin. Second, state-of-the-art NLP techniques (spaCy NLP framework, v2.0.0a16; GloVe word vectors; convolutional neural network;, TIGER Corpus) were utilized to train an industrystandard German language model for pathological EHRs by transfer learning. Finally, accuracy of the named entity extractors was compared to gold-standard encodings. CONCLUSIONS: Semi-automatic data extraction is precise and efficient. Moreover, this approach is scalable and based on an established state-of-the art NLP software library, where most recent technical NLP advancements can be utilized easily. In consequence, our approach is generalizable to other genitourinary EHRs and tumor entities.
Source of Funding: none

MP70-02 AN OVERVIEW OF PUBLICLY AVAILABLE PATIENT-CENTERED PROSTATE CANCER DATASETS
Tim Hulsen*, Eindhoven, Netherlands; Chris Bangma, Rotterdam, Netherlands INTRODUCTION AND OBJECTIVES: Prostate cancer (PCa) is the second most common cancer in men, and the second leading cause of death from cancer in men. Many studies on PCa have been carried out, each taking much time before the data is collected and ready to be analyzed. However, on the internet there is already a wide range of PCa datasets available, which could be used for data mining, predictive modelling or other purposes, reducing the need to setup new studies to collect data. In the current scientific climate, moving more and more to the analysis of 'big data' and large, international, multi-site projects, these datasets could be proven extremely valuable. This review presents an overview of publicly available patient-centered PCa datasets, divided into three categories (clinical, genomics and imaging) and an 'overall' section to enable researchers to select a suitable dataset for analysis, without having to go through days of work to find the right data.
METHODS: Scientific literature databases and academic social network sites were searched to acquire a list of human PCa databases. We also used the information from other reviews, and asked experts for their input. All databases in the combined list were then checked for public availability. Only databases that were either directly publicly available or available after signing a research data agreement or retrieving a free login were selected for inclusion in this review. Data should be available to commercial parties as well. This paper focuses on patient-centered data, so the genomics data section does not include gene-centered databases or pathway-centered databases.
RESULTS: We identified 40þ publicly available, patient-centered PCa datasets. Some of these consist of different smaller datasets. Some of them contain combinations of datasets from the three data domains: clinical data, imaging data and genomics data. Only one dataset contains information from all three domains. This review presents all datasets and their characteristics: number of subjects, clinical fields, imaging modalities, expression data, mutation data, biomarker measurements, etc.
CONCLUSIONS: Despite all the attention that has been given to making this overview of publicly available databases as extensive as possible, it is very likely not complete, and will also be outdated soon. However, this review might help many PCa researchers to find suitable datasets to answer the research question with, without the need to start a new data collection project. In the coming era of big data analysis, overviews like this are becoming more and more useful.
Source of Funding: Tim Hulsen is a researcher for Royal Philips.
MP70-03 PUDENDAL NERVE SOMATOSENSORY EVOKED POTENTIALS IN PATIENTS WITH POSTPROSTATECTOMY INCONTINENCE AND ERECTILE DYSFUNCTION
Se Yun Kwon*, Jin-Mo Park, Ki Ho Kim, Young Jin Seo, Kyung Seop Lee, Gyeongju, Korea, Republic of INTRODUCTION AND OBJECTIVES: Pudendal nerve somatosensory evoked potential (SSEP) has been studied in voiding and erectile dysfunctions. We aimed to evaluate correlation with pudendal nerve SSEP and functional outcome in patients undergoing radical prostatectomy.
METHODS: We retrospectively analyzed data from 44 patients who underwent radical prostatectomy from January 2014 and December 2016, with at least 6 months of follow-up. Patients were divided into 2 groups depending on the presence/absence of incontinence and erectile dysfunction, respectively. Patient demographic characteristics, preoperative evaluations, postoperative outcomes and pudendal nerve SSEP were assessed. Erectile function recovery was defined as question 2 and 3 on the Ineternational Index of Erectile Function (IIEF)-5 and continence was defined as using no pads.
RESULTS: Patients with/without postoperative incontinence were 22 and 22, respectively. Demographic characteristics and perioperative outcome were similar between 2 groups except pathologic stage (p¼0.038). Patients with/without postoperative erectile dysfunction were 11 and 33, respectively. Demographic characteristics and e934 THE JOURNAL OF UROLOGY â Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018 
